Abstract
Secondary hyperlipoproteinemias are those disorders of lipid metabolism, generally characterized by hyerlipoproteinemia (HLP) phenotypes II or IV, which occur in the course of various parenchymal, endocrinological or infectious diseases or during certain nutritional, toxicological or pharmacological manipulations. They are—by definition—reversible with successful treatment of the underlying defect (1). They are equally attractive for clinicians and biochemists for several reasons: 1) they are very common; 2) they provide valuable diagnostic and therapeutical information for the physician; 3) they are potentially atherogenic, at least with chronic diseases such as diabetes mellitus or kidney ailments; 4) secondary HLP represent, because of their inducibility, “natural models“ for studies of pathogenesis of lipid and lipoprotein disorders.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Klose G, Windier E, Greten H (1982) Befunde zur Pathogenese sekundärer Hyper-lipoproteinämien. In: Fortschritte in der Inneren Medizin, Kommerell B, Hahn P, Kübler W, Morl H, Weber E (ed) Springer-Verlag Berlin Heidelberg New York, p. 170–177
Havel RJ, Eder HA, Bragdon JH (1955) Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1354
Patsch JR, Gotto AM (1979) Separation and analysis of HDL subclasses by zonal ultracentrifugation. In: Report of the High Density Lipoprotein Methodology Workshop. Lippel K (ed) NIH Publ. 79–1661: 310–324
Fröhling W, Stiehl A (1976) Bile salt glucuronides: Identification and quantitative analysis in the urine of patients with cholestasis. Europ J Clin Invest 6: 67–74
Riesen W, Mordasini R, Middelhoff G (1978) Quantitation of the two major apoproteins of human high density lipoproteins by solid phase radioimmunoassay. FEBS Letters 91: 35
Heuck CC, Middelhoff G (1978) Vergleichende Untersuchung der Bestimmung von Apolipoprotein B. Fresenius Z Anal Chem 290: 127–128
Middelhoff G, Mordasini R, Stiehl A, Greten H (1979) A bile-acid-rich high density lipoprotein (HDL) in acute hepatitis. Scand J Gastroent 14: 267–272
Igimi H, Carey MC (1980) pH-solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena. J Lipid Res 21: 72–90
Manzato E, Fellin R, Baggio G, Walch S, Neubeck W, Seidel D (1976) Formation of lipoprotein-X. Its relationship to bile compounds. J Clin Invest 57: 1248–1260
Sabesin SM, Hawkins HL, Kuiken L, Rag I and J B (1977) Abnormal plasma lipoproteins and lecithin-cholesterol acy I transferase deficiency in alcoholic liver disease. Gastroenterology 72: 510–518
Klose G, Windelband J, Weizel A, Greten H (1977) Secondary hypertriglyceridemia in patients with parenchymal liver disease. Europ J Clin Invest 7: 557–562
Gherardi E, Vecchia L, Calandra S (1980) Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside, plasma and urinary lipoprotein. Exp Mol Pathol 32: 128
DeMendoza SG, Kashyap ML, Chen CJ, Lutmo RF (1976) High density lipoproteins in nephrotic syndrome. Metabolism 25: 1143
Felts JM, Mayerle JA (1975) Urinary loss of plasma high density lipoprotein - a possible cause of hyperlipidemia of the nephrotic syndrome. Circulation 50: III
Oetliker O, Mordasini R, Lütschg J, Riesen W (1980) Lipoprotein metabolism in nephrotic syndrome in childhood. Pediat Res 14: 64
Kekki M, Nikkilä E (1971) Plasma triglyceride metabolism in adult nephrotic syndrome Europ J Clin Invest 1: 345
Söbris R, Petersson BG, Nilsson-Ehle P (1981) Effects of weight reduction on plasma lipoproteins and adipose tissue metabolism in obese subjects. Europ J Clin Invest 11: 491–498
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Middelhoff, G., Därr, W., Schettler, G. (1983). Pathogenesis of Secondary Hyperlipoproteinemia. In: Schettler, F.G., Gotto, A.M., Middelhoff, G., Habenicht, A.J.R., Jurutka, K.R. (eds) Atherosclerosis VI. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81817-2_95
Download citation
DOI: https://doi.org/10.1007/978-3-642-81817-2_95
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81819-6
Online ISBN: 978-3-642-81817-2
eBook Packages: Springer Book Archive